Select Page

NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of GoHealth, Inc. (NASDAQ: GOCO) pursuant and/or traceable to the registration statement issued in connection with the Company’s July 2020 initial public offering (the “IPO”).
To join the class action, go to or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email for information on the class action.如果您想加入这个集体诉讼案,请在这里提交您的信息。 you wish to serve as lead plaintiff, you must move the Court before the NOVEMBER 20, 2020 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:  the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company’s concentrated carrier business model, and GoHealth’s efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
tel: (800) 991-3756